- Home
- NURO vs HOTH Comparison
NURO vs HOTH Comparison
Compare NURO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- HOTH
- Stock Information
- Founded
- NURO 1996
- HOTH 2017
- Country
- NURO United States
- HOTH United States
- Employees
- NURO N/A
- HOTH N/A
- Industry
- NURO Medical/Dental Instruments
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- NURO Health Care
- HOTH Health Care
- Exchange
- NURO Nasdaq
- HOTH Nasdaq
- Market Cap
- NURO N/A
- HOTH 8.3M
- IPO Year
- NURO N/A
- HOTH 2019
- Fundamental
- Price
- NURO $4.35
- HOTH $0.86
- Analyst Decision
- NURO
- HOTH Strong Buy
- Analyst Count
- NURO 0
- HOTH 3
- Target Price
- NURO N/A
- HOTH $4.00
- AVG Volume (30 Days)
- NURO 3.5K
- HOTH 609.6K
- Earning Date
- NURO 05-14-2025
- HOTH 05-13-2025
- Dividend Yield
- NURO N/A
- HOTH N/A
- EPS Growth
- NURO N/A
- HOTH N/A
- EPS
- NURO N/A
- HOTH N/A
- Revenue
- NURO $3,032,837.00
- HOTH N/A
- Revenue This Year
- NURO N/A
- HOTH N/A
- Revenue Next Year
- NURO N/A
- HOTH N/A
- P/E Ratio
- NURO N/A
- HOTH N/A
- Revenue Growth
- NURO N/A
- HOTH N/A
- 52 Week Low
- NURO $2.66
- HOTH $0.58
- 52 Week High
- NURO $4.73
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- NURO 47.71
- HOTH 43.67
- Support Level
- NURO $4.28
- HOTH $0.74
- Resistance Level
- NURO $4.45
- HOTH $0.87
- Average True Range (ATR)
- NURO 0.06
- HOTH 0.06
- MACD
- NURO -0.00
- HOTH 0.01
- Stochastic Oscillator
- NURO 52.63
- HOTH 71.91
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.